Minority Institutions' Drug Abuse Research Development Program (MIDARP)

Description:
Estimated Total Program Funding: Up to $350,000 per year in direct costs for 3-5 years.

The purpose of this program is to increase the capacity of minority institutions to conduct research in drug abuse and addiction. Grants will be provided to foster the research career development of racial/ethnic minority faculty, students, and staff who are underrepresented in drug abuse research and to conduct research in the drug abuse and addiction research area. All capacity development and research activities must address scientific areas related to the mission and priorities of the National Institute on Drug Abuse.

The overall goal of this RFP is to develop the capacity of the applicant institution to support drug abuse research through the following objectives:

1. provide under-represented minority faculty with drug abuse research knowledge and skill development through the conduct of research projects and other professional development activities
2. encourage under-represented minority students to pursue drug abuse research careers by providing them with educational enrichment and research experiences ; and
3. strengthen the underlying institutional infrastructure needed to support drug abuse research.

Research in any area of drug abuse research supported by NIDA is permissible. NIDA is interested in biomedical, clinical, and behavioral research and supports research on drug abuse in the following broad areas: epidemiology, etiology, prevention, treatment and services, basic research, and medications development. Research areas of particular interest are on HIV/AIDS as it relates to drug use and abuse and understanding disparities in health related to drug abuse and addiction experienced by racial/ethnic minority populations. Some areas of research such as studies that focus primarily on alcohol use may not be appropriate for primary assignment to NIDA. Applicants are encouraged to consult with NIDA staff before submitting an application to ensure that the chosen area of research focus is appropriate to NIDA's mission.

Each application must have a thematic research focus around which all research and training activities are directed. That is, there must be a common research issue or question (e.g., prevention with young adults, what increases adherence to treatment protocols in African Americans) that unites proposed institutional infrastructure development, faculty and student research development activities, and research projects.

Each applicant must provide

1. a description of the institution's current drug abuse research capacity,
2. a faculty development plan,
3. a student recruitment and development plan,
4. research projects,
5. an institutional research infrastructure development plan,
6. justification for the choice of the proposed Program Director (Principal Investigator),
7. the inclusion and description of an external advisory board,
8. a letter of institutional commitment signed by a Dean or other institutional official with authority to commit institutional resources, and
9. an impact assessment statement.

Sponsor(s):
US Department of Health and Human Services
National Institutes of Health
National Institute on Drug Abuse

Funder's Fund ID: PAR-05-069

Web Page:
http://grants.nih.gov/grants/guide/pa-files/PAR-05-069.html

Letter of Intent Date: 07/15/2005
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity.
Application Due Date: 08/16/2005
Peer Review Date: December, 2005
Council Review Date: May, 2006
Project Start Date: 05/01/2006

Letter of Intent Date: 03/13/2006
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 04/12/2006
Peer Review Date: August, 2006
Council Review Date: February, 2007
Project Start Date: 02/01/2007

Letter of Intent Date: 07/17/2006
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 08/16/2006
Peer Review Date: December, 2006
Council Review Date: May, 2007
Project Start Date: 05/01/2007

Letter of Intent Date: 03/12/2007
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 04/12/2007
Peer Review Date: August, 2007
Council Review Date: February, 2008
Project Start Date: 02/01/2008

Letter of Intent Date: 07/16/2007
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 08/16/2007
Peer Review Date: December, 2007
Council Review Date: May, 2008
Project Start Date: 05/01/2008

Letter of Intent Date: 03/12/2008
The LOI should include the following information:
Descriptive title of proposed research;
name, address, and phone no. of PI;
names of other key personnel;
participating institutions; and
no. and title of this funding opportunity
Application Due Date: 04/12/2008
Peer Review Date: August, 2008
Council Review Date: February, 2009
Project Start Date: 02/01/2009

Fund Duration: 3-5 years.

Application Process:
Applications must be prepared using the PHS 398 research grant application instructions and forms (rev. 9/2004); The PHS 398 document is available in an interactive format at grants.nih.gov/grants/funding/phs398/phs398.html.

Additional instructions for R21 application preparation are available at grants.nih.gov/grants/guide/pa-files/PA-03-107.html.

For further assistance contact GrantsInfo, Telephone (301) 435-0714, Email: Grantsinfo@nih.gov.

Applications must have a D&B Data Universal Numbering System (DUNS) number as the universal identifier when applying for Federal grants or cooperative agreements. The D&B number can be obtained by calling (866) 705-5711 or through the web site at www.dnb.com/us/.

Eligible Locations: National

Fund Notes:
This is a reissue of PAR-02-016, which was previously released October 22, 2001.

Application Contact Name: Gary Fleming, Chief, Grants Mgt. Branch/OPRM

Application Contact Address:
DHHS/NIH/NIDA
6101 Executive Blvd., Rm. 270
Bethesda, MD 20892
United States
E-mail: gfleming@nida.gov
Phone: 301- 443-6710
Fax: 301- 594-6849

Technical Contact Name:
Lula Beatty

Technical Contact Address:
NIDA, Special Populations Off.
6001 Executive Blvd.
Rm. 4216, MSC 9567
Bethesda, MD 208929567
United States
E-mail: lb75x@nih.gov
Phone: 301- 443-0441
Fax: 301- 480-8179

Support Types:
Research

Subject Areas:
Behavioral Research
Clinical Research
Drug Abuse
Epidemiological Research
Research Programs

Audiences:
African Americans/Blacks
Asians/Pacific Islanders
Hispanics/Latinos
Injecting Drug Users
Minorities
Native Americans
Substance Abusers

Eligibility:
Colleges/Universities
Minority Owned Organizations
Nonprofit Organizations
Tribal Organizations

Eligibility Notes:
Institutions applying for this award must demonstrate eligibility through

1. minority designation or
2. minority status and research capacity development need.

Applications may be submitted by an organization, university or college that meets one of the following criteria regarding minority classification:

1. A public or private nonprofit university, four-year college, or other institution offering undergraduate or graduate degrees with a traditionally high (more than 50 percent) minority (Black, Hispanic, Native American or Alaskan Native, Asian or Pacific Islander) student enrollment. This category of minority designated institutions comprises Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions (HSIs), and Tribal Colleges. An Indian tribe, which in conjunction with one or more institutions of higher learning, offers undergraduate and graduate degrees in disciplines relevant to drug abuse, which has a recognized governing body, and which performs substantial governmental functions, or an Alaska Regional Corporation (ARC) as defined in the Alaska Native Claims Settlement Act (43 U.S.C. 1601 et seq.) is eligible.
2. A college or university with an under-represented minority student enrollment of at least 25% in each of the previous five years.

In addition, these minority status applicants must demonstrate commitment to under-represented minority research development goals through

1. evidence of efforts to recruit faculty and students who are members of minorities nationally underrepresented in behavioral and biomedical research, and
2. demonstration of efforts to provide research support and resources to underrepresented minority faculty and students.